SCHEMBL26645645

SCHEMBL26645645

CC1c2c(I)c(-c3ccc(C(F)(F)F)cc3)nn2CCN1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 4/20 0.41
▸ HTR3A P46098 1/20 0.38
▸ UGCG Q16739 1/20 0.38
▸ CHRNB2 P17787 5/20 0.36
▸ CHRNB4 P30926 5/20 0.36
▸ CHRNA3 P32297 5/20 0.36
▸ CHRNA4 P43681 5/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TACR3 P29371 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ CKS1B P61024 1/20 0.34
▸ SKP1 P63208 1/20 0.34
▸ SKP2 Q13309 1/20 0.34
▸ TRPM2 O94759 1/20 0.33
▸ MARS1 P56192 1/20 0.33
▸ KDM1A O60341 1/20 0.33
▸ KCNK3 O14649 1/20 0.33
▸ SCN5A Q14524 1/20 0.33
▸ SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30622921 0.87 NR1H2 (0.40) SMOHTR3AUGCGCHRNB2CHRNB4
SCHEMBL26645124 0.87 NR1H2 (0.40) SMOHTR3AUGCGCHRNB2CHRNB4
SCHEMBL26645086 0.87 CSNK1E (0.39) SMOHTR3AUGCGCHRNA3MEN1
SCHEMBL30623093 0.83 TRPM2 (0.35) SMOHTR3AUGCGCHRNB2CHRNB4
SCHEMBL26645392 0.79 SMO (0.43) SMOHTR3AUGCGCHRNB2CHRNB4
SCHEMBL26645185 0.79 SMO (0.43) SMOHTR3AUGCGCHRNB2CHRNB4
SCHEMBL26645527 0.77 CSNK1E (0.41) SMOKCNK3
SCHEMBL30622862 0.76 CSNK1D (0.37) UGCGMEN1KMT2A
SCHEMBL26645130 0.76 CSNK1D (0.37) UGCGMEN1KMT2A
SCHEMBL26645434 0.74 GRM5 (0.39) SMOCHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback